General Information
Revision date
2011-04-27
Product name
2"-Deoxyguanosine 5"-Triphosphate, 100 mM solution (dGTP) Bulk; Part of "dNTP Validation Pack"
CAS No.
2564-35-4
supplier name
GE Healthcare UK Ltd
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
Section 2
SECTION 2: Hazards identification
This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Physical state Liquid. Odor Odorless. OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview CONTAINS MATERIAL THAT MAY CAUSE TARGET ORGAN DAMAGE, BASED ON ANIMAL DATA.
Potential Acute Health Effects
Eyes No known significant effects or critical hazards. Skin No known significant effects or critical hazards. Inhalation Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion No known significant effects or critical hazards.
Potential chronic health
effects Contains material that may cause target organ damage, based on animal data. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which may cause damage to the following organs: mucous membranes, upper respiratory tract. Inhalation No specific data. Ingestion No specific data. Skin No specific data. Eyes No specific data.
Medical Conditions Generally Aggravated by Exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be over-exposure aggravated by over-exposure to this product. See toxicological information (Section 11)